This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Ionis Pharmaceuticals, Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Brooke A. Anderson: Innovator in Oligomeric Compounds
Introduction
Brooke A. Anderson is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of modified oligomeric compounds. Her work has implications for various applications, including antisense agents.
Latest Patents
Brooke holds a patent for "Linkage modified oligomeric compounds and uses thereof." This patent provides a detailed disclosure of oligomeric compounds that include modified oligonucleotides with at least one modified internucleoside linking group. This innovation is crucial for advancing therapeutic strategies in genetic research and treatment.
Career Highlights
Brooke A. Anderson is currently employed at Ionis Pharmaceuticals, Inc., where she continues to push the boundaries of scientific research. Her expertise in oligomeric compounds has positioned her as a key player in the biotechnology sector.
Collaborations
Throughout her career, Brooke has collaborated with notable colleagues, including Xue-hai Liang and William John Drury III. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Brooke A. Anderson's contributions to the field of biotechnology through her patented innovations exemplify her dedication to advancing science. Her work at Ionis Pharmaceuticals, Inc. continues to impact the development of therapeutic solutions.